Catalyst Wire Dossier Catalyst Wire Dossier

PegIFN Alfa

pegylated interferon alfa
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PegIFN Alfa, covering 2019-01-15 to 2019-01-15. Get the full timeline:

Most recent: Clinical Trial Update: The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg [Phase 4]

See pricing